BACKGROUND Foam sclerotherapy is an effective treatment strategy for varicose veins and venous malformations. Foam stability varies according to foam composition, volume, and injection technique.
F oam sclerotherapy is an effective and commonly used treatment strategy for varicose veins and venous malformations. [1] [2] [3] Polidocanol (POL) is the most widely used sclerosant agent. Stability is one of the characteristics of sclerosant foams that determines their sclerosing power. 4 Foam stability has been reported to be influenced by different gases, methods of preparation, 5 the liquid air fraction, 6 sclerosant concentration, 7 and temperature. 8 Viscosity is an important influential factor for the sclerosant foam stability. 5 Some articles on the influence of the addition of glycerin to sclerosant agentsodium tetradecyl sulphate and POL-have been recently published, the addition of glycerin to a sclerosant foam can prolong foam stability due to the increased viscosity of glycerin. 9, 10 Hyaluronic acid (HA) is an autologous substance that exists in the blood at a certain concentration. 11 Intravenous injection of 0.03 to 0.75 g/L concentrations of HA in humans was reported to be safe. 12, 13 Hyaluronic acid is a natural linear glycosaminoglycan that is biodegradable, nontoxic, and nonimmunogenic 14 and it is viscose. It is soluble in water and, therefore, absolutely chemically compatible with POL. We found that the POL foam stability was influenced by the addition of HA. Few studies have been performed on the POL foam influenced by the addition of HA.
The aim of this article was to describe POL foam stability variation based on its association with HA.
Materials and Methods
The materials included POL (1% lauromacrogol injection; Shanxi-Tianyu, Xian City, China); HA with a molecular weight of 150 to 250 kDa, noncrosslinked, derived from bacteria (20 mg/2 mL Sofast Sodium Hyaluronate Injection; Shandong Bauschfruida Pharmaceutical Co Ltd., Shandong, China); air at room temperature; 10-mL silicone-free syringe (WEGO, Weihai City, China); and 3-way tap (WEGO).
Tessari's method 15 was used to generate sclerosant foam. Twenty passes were performed in the standard way to obtain the foam. The new syringes and 3-way taps were used for each test. Room temperature was controlled at 22°C.
Three groups were studied in this experiment: Group A: 2 mL of 1% POL + 0 mL of 1% HA + 8 mL of air; Group B: 2 mL of 1% POL + 0.05 mL of 1% HA + 8 mL of air; Group C: 2 mL of 1% POL + 0.1 mL of 1% HA + 8 mL of air.
The half-life, or the time for a volume of foam to be reduced to half of its original volume (half-volume), was used to evaluate foam stability like in other works. 7, 9 When the foam filled the 10-mL syringe, the syringe was disconnected from the 3-way tap and placed exactly vertical with the rubber plug of the syringe on the bottom. The timer was started. Over the course of time, as the foam degenerated back into its constituents, the sclerosant solution was found to gradually reform at the bottom of the syringe. When the bottom of the solution's meniscus attained an exact volume of 1.0 mL as measured by the scale on the side of the syringe, the timer was stopped. The time was recorded in seconds and the time was the half-life. Five sets of duplicate half-lives in Group A, Group B, and Group C were measured.
Results
After 5 sets of recordings were gathered for all 3 groups of the study, it was found that the half-life was greater when HA was combined with POL. The half-lives were 139 to 150 (mean 142.8 6 4.32) seconds for 1% POL without the addition of HA, 300 to 320 (mean 310.6 6 7.53) seconds with the addition of 0.05 mL of 1% HA, and 373 to 405 (mean 390.4 6 13.06) seconds with the addition of 0.1 mL of 1% HA. These results are summarized in Table 1 .
Discussion
Liquid sclerosants have the disadvantage of being diluted by the blood, resulting in an insufficient level of the desired effect at the injection site. In contrast, foam sclerosant displace the blood instead of mixing with it and occupy the interior of blood vessels. [16] [17] [18] Stability is one of the characteristics of sclerosant foams that determines their sclerosing power. 4 Foam stability has been reported to be influenced by different gases and methods of preparation, 5 the liquid air fraction, 6 and sclerosant concentration. 7 Low temperature can enhance the stability of POL foam. 8 Another agent that has been reported to enhance the stability of POL foam is glycerin; the longest half-time recorded for POL supplemented with glycerin was 280 seconds for 3% POL with 1.66% glycerin. 10 In our study, the addition of HA prolonged the POL foam half-life by 173.38%.
Hyaluronic acid is a natural linear glycosaminoglycan and is more viscous than POL. Hyaluronic acid alone cannot be made into the foam with air; however, small amounts of it can enhance the stability of POL foam, although the mechanism behind this is unclear. We presumed that this effect is mostly due to enhancement of foam viscosity. Viscosity is an important influential factor on sclerosant foam stability 5 ; high viscosity enhances foam homogeneity and stability. It is reasonable to conclude that increased viscosity generated by the addition of HA strongly enhanced the stability of the foam.
In this study, our experimental data supported that the addition of HA could prolong the half-life of POL foam. We may speculate the prolonged half-life of POL/HA foam could result in a more efficacious sclerotherapy result due to a prolonged contact time of the foam bubbles with the endothelial cells. There also exist a potential that owing to prolonged foam half-life and slower pace of degradation, the occurrence of distant air embolism may be reduced. However, safety and efficacy studies in a clinical setting are necessary.
Conclusion
This study revealed that the stability of POL foam is highly increased by the addition of small amounts of HA.
